Nasal Drug Delivery
Pradeep K. Karla(Howard University), Ashim K. Mitra(University of Missouri–Kansas City), Ripal Gaudana(University of Missouri–Kansas City), Deep Kwatra(University of Kansas Medical Center)
Cited by 3
Related Papers
Recent Perspectives in Ocular Drug Delivery
|Pharmaceutical Research|2008|596
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
|Pharmaceutics|2018|408
Methanolic Extracts of Bitter Melon Inhibit Colon Cancer Stem Cells by Affecting Energy Homeostasis and Autophagy
|Evidence-based Complementary and Alternative Medicine|2013|72
Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
|Molecular Pharmacology|2010|68
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65